Luis R. Costa

Viana Do Castelo, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Early versus late starting of direct oral anticoagulants after breakthrough ischemic stroke: A target trial analysis from the ASPERA-R study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Early versus Late starting of Direct Oral Anticoagulants after breakthrough ischemic stroke: A Target Trial Analysis from the ASPERA-R Study.

Journal: International journal of stroke : official journal of the International Stroke Society

Published: June 19, 2026

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Decoding the causes of ischemic stroke despite ongoing oral anticoagulation and their clinical impact: the ASPERA-R study.

Journal: Journal of neurology

Published: May 20, 2026

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Continuation vs Switching Direct Oral Anticoagulant Therapy After Breakthrough Stroke.

Journal: JAMA network open

Published: April 28, 2026

Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.

Competing Stroke Etiologies and Outcomes After Breakthrough Ischemic Stroke on Oral Anticoagulants in Patients With Atrial Fibrillation.

Journal: Neurology

Published: April 13, 2026

Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis.

Posterior versus anterior circulation infarct location and outcomes after breakthrough ischemic stroke in orally anticoagulated patients for atrial fibrillation: An ASPERA-R inverse probability-weighted analysis.

Journal: Journal of the neurological sciences

Published: April 01, 2026

PARKinSOUND 2.0: Impact of Participation in an Orchestra in Patients with Parkinson's Disease.

PARKinSOUND 2.0: Impact of Participation in an Orchestra in Patients with Parkinson's Disease.

Journal: Movement disorders clinical practice

Published: December 19, 2025

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Impact of cancer on outcomes following breakthrough ischaemic stroke on oral anticoagulants for atrial fibrillation: insights from the ASPERA-R study.

Journal: European stroke journal

Published: November 20, 2025

Prevalence and prognostic impact of anemia and iron deficiency in patients hospitalized in an internal medicine ward: The PRO-IRON study.

Prevalence and prognostic impact of anemia and iron deficiency in patients hospitalized in an internal medicine ward: The PRO-IRON study.

Journal: European journal of haematology

Published: September 01, 2017

A case of fulminant Type 1 diabetes following anti-PD1 immunotherapy in a genetically susceptible patient.

A case of fulminant Type 1 diabetes following anti-PD1 immunotherapy in a genetically susceptible patient.

Journal: Immunotherapy

Published: June 10, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026